The phrase "ancillary mechanisms" is correct and usable in written English.
It can be used in contexts where you are referring to supplementary or additional processes or systems that support a primary function or operation.
Example: "The study examined the ancillary mechanisms that contribute to the overall effectiveness of the treatment."
Alternatives: "supporting systems" or "additional processes".
Several ancillary mechanisms have been proposed to explain metformin induced cardioprotection, these are displayed in detail in Fig. 2 [ 12– 33].
Since metformin would seem to act through cellular energy regulation, diet and exercise operate to reduce cancer risk in a similar way, although gender differences indicate that ancillary mechanisms and preventive and management approaches may be possible.
The predominant strategy for overcoming resistance is to combine drugs that act through ancillary mechanisms to block the functional redundancies and compensatory signaling pathways that serve as escape routes for cell survival.
A relatively small number of genes (150) were differentially regulated between Dyrk1a knockdown and harmine treatment, which may in part reflect ancillary mechanisms engaged by harmine to regulate Treg/Th17 differentiation.
It is relevant to try to point out the real weight of ancillary mechanisms, for example the anti-inflammatory effects exerted by RAS-active drugs, in preventing macrovascular complications in type 2 diabetes.
Another intriguing possibility was recently put forward by Javid et al. [ 70], who argue that protein variability driven by errors in the central information-processing pathway (DNA-RNA-protein) may provide a phenotypic stepping-stone to resistance akin perhaps to other ancillary mechanisms shown in Fig. 1.
The oath is an ancillary mechanism to commit bidders to bid sincerely in a second-price auction.
These results suggest that co-culture between adipocytes with ATMs/ASCs may generate of CD68 /preadipocytepocell cell spheres in an ancillary mechanism to the proliferation of new preadipocytes in humans.
VEGF produced and released by endothelial cells is regarded as an ancillary mechanism supporting their own survival and proliferation in an autocrine fashion (Villegas et al, 2005), as it has been described, for instance, in ischaemic tissues (Seghezzi et al, 1998).
Many production applications still implement legacy code that contains little to no native or ancillary security mechanisms.
Moreover Prf-2 may work in conjunction with known defenses (i.e. the statement in the third paragraph of the Introduction that P-2 is not ancillary to other mechanisms is unproven).
